Lina Titievsky
Company: GlaxoSmithKline Plc
Job title: Senior Director & Head, Immunology and Opportunistic Epidemiology
Seminars:
Effectively Using RWE to Identify & Enrol Patients for Clinical Trials 3:20 pm
day: Conference Day Two
Utilizing RWE as a Component of Regulatory Submissions to Achieve FDA Approval 2:30 pm
• What type and level of RWE was required? • What does the engagement and timing with the FDA look like? • How do you prepare your RWE strategy early and demonstrate this to regulators?Read more
day: Conference Day One